Try our corporate solution for free!
(212) 419-8286

US and European private VC-backed orphan biopharma company M&A values 2014-2019

In 2016, the transaction volumes of private biopharma companies that do not product orphan products reached 19.6 billion U.S. dollars, whereas the values for companies that produce orphan products was 1.3 billion U.S. dollars. This statistic shows the M&A transaction volumes of private venture capital-backed orphan biopharma companies in U.S. and Europe from 2014 to 2019.

M&A transaction volumes of private U.S. and European VC-backed orphan biopharma companies from 2014 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020


Europe, United States

Survey time period

2014 to 2019

Supplementary notes

Total transaction values (including contingent payments) of completed trade sales of private VC-backed U.S. and European biopharma companies (all transaction sizes).

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Orphan drugs"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.